首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   27479篇
  免费   1443篇
  国内免费   155篇
耳鼻咽喉   149篇
儿科学   440篇
妇产科学   424篇
基础医学   3427篇
口腔科学   869篇
临床医学   1902篇
内科学   6822篇
皮肤病学   569篇
神经病学   2543篇
特种医学   1269篇
外科学   4305篇
综合类   102篇
预防医学   756篇
眼科学   442篇
药学   2094篇
中国医学   61篇
肿瘤学   2903篇
  2023年   127篇
  2022年   214篇
  2021年   477篇
  2020年   293篇
  2019年   415篇
  2018年   467篇
  2017年   353篇
  2016年   462篇
  2015年   458篇
  2014年   646篇
  2013年   748篇
  2012年   1192篇
  2011年   1413篇
  2010年   747篇
  2009年   683篇
  2008年   1246篇
  2007年   1303篇
  2006年   1282篇
  2005年   1282篇
  2004年   1269篇
  2003年   1306篇
  2002年   1322篇
  2001年   968篇
  2000年   984篇
  1999年   972篇
  1998年   385篇
  1997年   302篇
  1996年   273篇
  1995年   231篇
  1994年   199篇
  1993年   192篇
  1992年   688篇
  1991年   594篇
  1990年   624篇
  1989年   615篇
  1988年   512篇
  1987年   478篇
  1986年   465篇
  1985年   410篇
  1984年   291篇
  1983年   249篇
  1981年   98篇
  1980年   102篇
  1979年   248篇
  1978年   155篇
  1977年   135篇
  1975年   103篇
  1972年   107篇
  1971年   103篇
  1969年   102篇
排序方式: 共有10000条查询结果,搜索用时 875 毫秒
1.
2.
miRNA‐221 (miR‐221) is known to be abnormally expressed in many human cancers. The serum levels of miR‐221 have been reported as a tumor marker for malignant melanoma (MM). We hypothesized that the hair shaft miR‐221 levels may be increased in patients with MM. We therefore assessed the possibility that hair shaft miR‐221 levels could be a marker for MM. The hair shaft miR‐221 levels were significantly higher in patients with MM than controls. The rates of increased hair shaft miR‐221 levels above the cut‐off value were comparable to those of serum 5‐S‐CD, which is a tumor marker commonly used for MM. Measurements of the hair shaft miR‐221 levels could have potential clinical value in the detection of MM. This is the first report investigating the hair shaft levels of an miRNA in patients with MM. Our investigations offer new insight into the relationship between miR‐221 and MM, and may provide a new, non‐invasive way to screen for melanoma.  相似文献   
3.
Idiopathic myointimal hyperplasia of mesenteric veins (IMHMV) is a rare and poorly understood ischemic colitis that occurs in the rectosigmoid colon of predominantly young, previously healthy, male patients. A 76‐year‐old Japanese man presented to our hospital with a 1‐year history of worsening diarrhea, lower abdominal pain, and weight loss (−6 kg). Laboratory evaluation revealed white blood cell count of 13 200/μL, C‐reactive protein level of 2.0 mg/dL (normal range, 0.0–0.3), and negative results for stool culture (including Clostridium difficile). Colonoscopy showed circumferential and edematous narrowing of the sigmoid colon with deep longitude ulceration. Biopsy was done and examination of the specimen demonstrated no specific ischemia. The patient was treated with bowel rest, antibiotics, and i.v. fluids; however, his symptoms worsened. Finally, sigmoidectomy was carried out. Histological examination demonstrated significant myointimal hyperplasia of mesenteric veins leading to thickening and stenosis of the venous lumen. Therefore, the final diagnosis was IMHMV. Three months following sigmoidectomy, he was asymptomatic.  相似文献   
4.
5.
6.
7.
8.
Background: Gastrointestinal stromal tumors (GIST) are one of the most common mesenchymal tumors of the gastrointestinal tract. GIST are defined by positive immunohistochemical staining for KIT or CD34 and thus are generally diagnosed after surgery. Because small GIST are rarely diagnosed before surgery, the clinical course of these small tumors is not clear. The aim of the present study was to follow changes in size and configuration of small GIST that were pathologically confirmed using endoscopic ultrasonography‐guided fine‐needle aspiration biopsy (EUS‐FNAB). Methods: Between July 1997 and December 2003, 16 tumors in 16 patients (10 men and 6 women) with an immunohistochemical diagnosis of GIST were regularly followed in our hospital. The median patient age when EUS‐FNAB was performed was 62 years (range 26–82 years) and the median follow‐up period was 4.9 years (range 0.5–9.6 years). Results: Fourteen tumors showed no remarkable changes in size and shape during follow up compared with the initial diagnosis. Two tumors enlarged: one tumor approximately doubled its diameter in 8 years and the other tumor increased from 1.8 cm at diagnosis to up to 10 cm after only 2 years. Doubling time of the latter tumor was calculated as 3.1 months. Conclusions: We conclude that EUS‐FNAB might be a good modality for final diagnosis of GIST without surgery, and that GIST without rapid growth on follow up can be endoscopically followed.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号